Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)

Zhejiang University219 enrolled

Overview

Conduct comparative experimental studies on clinical serum samples using assessment reagents and approved products, and evaluate the equivalence between assessment reagents and comparison reagents.

Study Type

OBSERVATIONAL

Enrollment

219

Conditions

Nephropathy

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: Clear background information and traceable sources of samples from kidney disease patients (number, age, gender, and clinical diagnostic information). Exclusion Criteria: Exclude serum samples that meet one of the following conditions: ① Samples with insufficient sample size, ② Samples with incomplete sample information.

Locations (1)

The First Affiliated hospital Zhejiang University school of medicine

Hangzhou, Zhejiang, China

Outcomes

Primary Outcomes

Calculate the correlation between the test reagents and comparison reagents

Time frame: 1 year.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.